NCUA Launches Streamlined Charter System Phase 1

The NCUA announced the launch of Phase 1 of a streamlined online charter application system, focusing on preliminary approval of a proposed credit union's field of membership. The system is part of a multi-phase effort to modernize credit union chartering, with a fully automated system expected in 2027. The December 2024 NCUA Board approved $2 million for system development.

Weekly Filings Summary - Proposed Decisions and New Applications

CPUC published its weekly filings summary for March 23-27, 2026, listing proposed decisions open for public comment and new complaints/applications. Key items include a proposed 10 percent rate increase for Crimson California Pipeline L.P. Southern California pipeline system (A25-06-026), a proposed decision on California climate credit improvements (R25-07-013), and applications for telecommunications numbering relief (A26-03-026), airport shuttle service (A26-03-027), regional energy network plans (A26-03-028), and Advanced Metering Infrastructure 2.0 deployment by Southern California Edison (A26-03-030).

Weekly Utility Filings - Proposed Decisions Open for Comment

The California Public Utilities Commission published its weekly listing of new utility filings for March 9-13, 2026. The listing includes three Proposed Decisions open for public comment (proceeding A2407003 involving rate increases through 2028, and C2508023 granting partial relief) and seven new applications including Southern California Edison cost recovery, Chevron rehearing request, and multiple telecommunications provider certificates of public convenience and necessity.

Texas AG sues Permian Basin Containers for environmental violations

Texas Attorney General Ken Paxton filed a lawsuit against Permian Basin Containers, LLC and related entities for environmental violations stemming from a catastrophic chemical fire at their Odessa facility on July 23, 2024. The fire released toxic substances including benzene into the air, soil, and groundwater, contaminating surrounding properties and endangering residents. The state seeks injunctive relief requiring full site remediation and recovery of cleanup costs and damages.

Paxton sues dental providers for Medicaid fraud, unnecessary procedures

Texas Attorney General Ken Paxton filed suit against dental providers and marketers for allegedly bribing Medicaid patients with gift cards and performing medically unnecessary dental procedures, defrauding Texas Medicaid. The lawsuit, brought under the Texas Health Care Program Fraud Prevention Act, seeks full restitution, civil penalties, and all available remedies. The case was initially sealed and has now been unsealed.

California AG $1.64M Settlement Over False Claims for Truck Reimbursements

California Attorney General Rob Bonta announced a $1.64 million settlement with commercial fleet lender Crossroads Equipment Lease and Finance over alleged false claims for reimbursements under the California Capital Access Program (CalCAP). A DOJ investigation validated whistleblower claims that Crossroads made minimal efforts to sell repossessed trucks knowing the program would reimburse losses. The settlement resolves claims raised under the California False Claims Act by a former Chief Risk Officer.

Lung cancer Phase 3 trial evaluating BL-B01D1 combination therapy

The National Library of Medicine registered a Phase 3 clinical trial (NCT07502300) on ClinicalTrials.gov evaluating BL-B01D1 combination therapy for lung cancer. This is a standard clinical trial registration providing public transparency about ongoing research. The trial involves evaluating the efficacy and safety of BL-B01D1 as a treatment intervention.

AI cognitive-behavioral therapy trial, major depressive disorder, Taiwan

ClinicalTrials.gov registered a new Phase 2 clinical trial (NCT07500714) evaluating AI-assisted cognitive-behavioral therapy for adult patients with major depressive disorder. The single-arm trial is conducted at National Taiwan University Hospital in Taiwan. The study uses the Woebot Health AI platform combined with standard pharmacotherapy over a 10-week intervention period.

HBS-301 Tablet Phase 3 for Idiopathic Hypersomnia

The National Institutes of Health posted a new clinical trial registration on ClinicalTrials.gov for HBS-301 tablets in Phase 3 evaluation for idiopathic hypersomnia. The trial is listed as currently recruiting participants. This registry posting does not impose new regulatory requirements but reflects compliance with clinical trial registration obligations.

Phase 3 Libevitug study for chronic HDV infection

The National Library of Medicine registered a Phase 3 clinical trial (NCT07499544) for Libevitug in chronic hepatitis D virus (HDV) infection on ClinicalTrials.gov. The trial is listed with standard registry metadata including sponsor information and study design. No specific regulatory deadlines or penalties are associated with this registration notice.